Citation Impact

Citing Papers

International consensus diagnostic criteria for neuromyelitis optica spectrum disorders
2015 Standout
Differential diagnosis of suspected multiple sclerosis: a consensus approach
2008
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
PD-1 + regulatory T cells amplified by PD-1 blockade promote hyperprogression of cancer
2019 StandoutNobel
High field MRI in the diagnosis of multiple sclerosis: high field–high yield?
2009
Passive Immunization with Anti-Ganglioside Antibodies Directly Inhibits Axon Regeneration in an Animal Model
2007
The natural history of multiple sclerosis:a geographically based study
1999
Effect of early versus delayed interferon beta-1b treatment on disability after a first clinical event suggestive of multiple sclerosis: a 3-year follow-up analysis of the BENEFIT study
2007
Prevalence and Clinical Significance of Anti-phospholipid Antibodies in Multiple Sclerosis: a Study of 89 Patients
2000
Increased circulating T cell reactivity to GM3 and GQ1b gangliosides in primary progressive multiple sclerosis
2003
MRI and the diagnosis of multiple sclerosis: expanding the concept of “no better explanation”
2006
Current trials in multiple sclerosis: established evidence and future hopes
2005
Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis
2008
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
2006 Standout
Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
2010 Standout
Application of the new McDonald criteria to patients with clinically isolated syndromes suggestive of multiple sclerosis
2002
The spectrum of neuromyelitis optica
2007 Standout
The cerebellum and cognition
2018 Standout
The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
2008 Standout
A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
2010 Standout
Spontaneous fluctuations in brain activity observed with functional magnetic resonance imaging
2007 Standout
Mechanisms Underlying Inflammation in Neurodegeneration
2010 Standout
Validity of the Prodromal Risk Syndrome for First Psychosis: Findings From the North American Prodrome Longitudinal Study
2009
B cells and antibodies in CNS demyelinating disease
2001
Treatment of progressive multiple sclerosis: what works, what does not, and what is needed
2015
Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis
2001 Standout
Accuracy of magnetic resonance imaging for the diagnosis of multiple sclerosis: systematic review
2006
Immunoserological changes in the cerebro-spinal fluid and serum in systemic lupus erythematosus patients with demyelinating syndrome and multiple sclerosis
2002
CNS myeloid DCs presenting endogenous myelin peptides 'preferentially' polarize CD4+ TH-17 cells in relapsing EAE
2007
An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor
2011 StandoutNature
The Neurovascular Unit Coming of Age: A Journey through Neurovascular Coupling in Health and Disease
2017 Standout
Prognostic Impact of Acute Myeloid Leukemia Classification: Importance of Detection of Recurring Cytogenetic Abnormalities and Multilineage Dysplasia on Survival
2003
Serum anti-GAGA4 IgM antibodies differentiate relapsing remitting and secondary progressive multiple sclerosis from primary progressive multiple sclerosis and other neurological diseases
2009
Guidelines on the investigation and management of antiphospholipid syndrome
2012
Guillain-Barré syndrome
2016 Standout
Reciprocal regulation of the Il9 locus by counteracting activities of transcription factors IRF1 and IRF4
2017 StandoutNobel
The radiologically isolated syndrome: take action when the unexpected is uncovered?
2010
Emerging oral therapies for multiple sclerosis
2007
US FDA-Approved Disease-Modifying Treatments for Multiple Sclerosis
2005
Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria
2006 StandoutNobel
Diagnosis of multiple sclerosis: progress and challenges
2016
Effects of extracellular matrix viscoelasticity on cellular behaviour
2020 StandoutNature
Multiple Sclerosis: Low-Frequency Temporal Blood Oxygen Level–Dependent Fluctuations Indicate Reduced Functional Connectivity—Initial Results
2002
Advanced MRI and staging of multiple sclerosis lesions
2016
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis
2008 Standout
Multiple sclerosis
2008 Standout
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
2013 Standout
Interferon β‐1a for early multiple sclerosis: CHAMPS trial subgroup analyses
2002
Detection of Cortical Inflammatory Lesions by Double Inversion Recovery Magnetic Resonance Imaging in Patients With Multiple Sclerosis
2007
Is it time to target no evident disease activity (NEDA) in multiple sclerosis?
2015
The pathology of primary progressive multiple sclerosis
2004
The epidemiology of multiple sclerosis
2016
Environmental risk factors and multiple sclerosis: an umbrella review of systematic reviews and meta-analyses
2015
Immunopathology of multiple sclerosis
2015 Standout
Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis
2011
Development, maintenance and disruption of the blood-brain barrier
2013 Standout
Rethinking schizophrenia
2010 StandoutNature
A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
2006 Standout
Differentiation of Multiple Sclerosis from Other Inflammatory Disorders and Cerebrovascular Disease: Value of Spinal MR Imaging
2002
IL-17A secretion by CD8+ T cells supports Th17-mediated autoimmune encephalomyelitis
2012
Revised Recommendations of the Consortium of MS Centers Task Force for a Standardized MRI Protocol and Clinical Guidelines for the Diagnosis and Follow-Up of Multiple Sclerosis
2015
Axonal Transection in the Lesions of Multiple Sclerosis
1998 Standout
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
2011 Standout
Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation
2016 Standout
Defining Disease Activity and Response to Therapy in MS
2017
Tryptophan degradation in autoimmune diseases
2007
Antibody Association with a Novel Model for Primary Progressive Multiple Sclerosis: Induction of Relapsing‐Remitting and Progressive Forms of EAE in H2S Mouse Strains
2000
Blood-Brain Barrier Breakdown in the Aging Human Hippocampus
2015 Standout
Interferon-β Suppresses Murine Th1 Cell Function in the Absence of Antigen-Presenting Cells
2015
Natalizumab for Multiple Sclerosis
2007
Absence of Neuromyelitis Optica IgG Antibody in an Active Relapsing-Remitting Multiple Sclerosis Population
2009
MRI prognostic factors for relapse after acute CNS inflammatory demyelination in childhood
2004
Increased circulating antiganglioside antibodies in primary and secondary progressive multiple sclerosis
1998
Initial Evaluations for Multiple Sclerosis in a University Multiple Sclerosis Center
2005
Myeloid cells — targets of medication in multiple sclerosis
2016
Validation of diagnostic magnetic resonance imaging criteria for multiple sclerosis and response to interferon β1a
2003
The cerebellar cognitive affective syndrome
1998 Standout
Defining trained immunity and its role in health and disease
2020 Standout
Long-term Follow-up of Acute Partial Transverse Myelitis
2012
Spinal cord MRI in clinically isolated optic neuritis
2003
Oligoclonal bands in multiple sclerosis cerebrospinal fluid: An update on methodology and clinical usefulness
2006
New T2 lesions enable an earlier diagnosis of multiple sclerosis in clinically isolated syndromes
2003
Modification of MRI criteria for multiple sclerosis in patients with clinically isolated syndromes
2005
Does high field MRI allow an earlier diagnosis of multiple sclerosis?
2008
Acute disseminated encephalomyelitis, multiphasic disseminated encephalomyelitis and multiple sclerosis in children
2000
Biomarkers in multiple sclerosis
2015
FoxA1 directs the lineage and immunosuppressive properties of a novel regulatory T cell population in EAE and MS
2014
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
2005 Standout
Spinal cord MRI in multiple sclerosis—diagnostic, prognostic and clinical value
2015
Multiple sclerosis
2002 Standout
Brain Viscoelasticity Alteration in Chronic-Progressive Multiple Sclerosis
2012
Effect of intramuscular interferon beta-1a on gray matter atrophy in relapsing−remitting multiple sclerosis: A retrospective analysis
2015
Immunomodulators and immunosuppressants for multiple sclerosis: a network meta-analysis
2013
QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy Studies
2011 Standout
The utility of MRI in suspected MS [RETIRED]
2003
Multiple sclerosis risk in radiologically uncovered asymptomatic possible inflammatory-demyelinating disease
2009
Revised diagnostic criteria for neuromyelitis optica
2006 Standout
Intracortical lesions
2010
The Biology of NKT Cells
2006 Standout
Multiple sclerosis diagnostic criteria: three years later
2005
Clinically isolated syndromes
2006
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
2009 Standout
Multiple Sclerosis
2018 Standout
Recurrent stroke on imaging and presumed paradoxical embolism
2012
Structural basis for CD1d presentation of a sulfatide derived from myelin and its implications for autoimmunity
2005
Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group
2008 Standout
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
2015 Standout
Standardized MR imaging protocol for multiple sclerosis: Consortium of MS Centers consensus guidelines.
2006
IMMUNOLOGY OF MULTIPLE SCLEROSIS
2005 Standout
Double inversion recovery brain imaging at 3T: diagnostic value in the detection of multiple sclerosis lesions.
2007
Primary progressive multiple sclerosis diagnostic criteria: a reappraisal
2009
How neuroinflammation contributes to neurodegeneration
2016 StandoutScience
Depressogenic effects of medications: a review
2011
The Potential of Mesenchymal Stromal Cells as a Novel Cellular Therapy for Multiple Sclerosis
2012
Analyses of cerebrospinal fluid in the diagnosis and monitoring of multiple sclerosis
2009
Association between clinical conversion to multiple sclerosis in radiologically isolated syndrome and magnetic resonance imaging, cerebrospinal fluid, and visual evoked potential: follow-up of 70 patients.
2009
Dendritic cells are specialized accessory cells along with TGF-β for the differentiation of Foxp3+ CD4+ regulatory T cells from peripheral Foxp3− precursors
2007 StandoutNobel
MRI criteria for multiple sclerosis
2004
High prevalence of autoreactive, neuroantigen-specific CD8+ T cells in multiple sclerosis revealed by novel flow cytometric assay
2004
Spinal cord abnormalities in recently diagnosed MS patients
2004
Flt3L controls the development of radiosensitive dendritic cells in the meninges and choroid plexus of the steady-state mouse brain
2011 StandoutNobel
Retrospective comparison of the original and revised McDonald criteria in a general neurology practice in Ireland
2007
Compliance with McDonald criteria and red flag recognition in a general neurology practice in Ireland
2010
Specific Proliferation Towards Myelin Antigens in Patients with Multiple Sclerosis During a Relapse
2002
The usefulness of brain MRI at onset in the differentiation of multiple sclerosis and seropositive neuromyelitis optica spectrum disorders
2013

Works of Mar Tintoré being referenced

Scoring treatment response in patients with relapsing multiple sclerosis
2012
MRI criteria for MS in patients with clinically isolated syndromes
2010
MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines
2016
Is optic neuritis more benign than other first attacks in multiple sclerosis?
2005
Interferon beta in secondary progressive multiple sclerosis
2007
Idiopathic inflammatory-demyelinating diseases of the central nervous system
2007
A three-year, multi-parametric MRI study in patients at presentation with CIS
2008
Will Rogers phenomenon in multiple sclerosis
2008
Treatment decisions in multiple sclerosis — insights from real-world observational studies
2017
Specificity of Barkhof Criteria in Predicting Conversion to Multiple Sclerosis When Applied to Clinically Isolated Brainstem Syndromes
2004
A Single, Early Magnetic Resonance Imaging Study in the Diagnosis of Multiple Sclerosis
2009
Altered maturation of circulating dendritic cells in primary progressive MS patients
2006
Lack of association between anticardiolipin antibodies and migraine in systemic lupus erythematosus
1992
Defining the response to interferon‐β in relapsing‐remitting multiple sclerosis patients
2006
MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis—clinical implementation in the diagnostic process
2015
The role of the cerebellum in multiple sclerosis—150 years after Charcot
2018
Rationale for early intervention with immunomodulatory treatments
2008
Different antiganglioside antibody pattern between relapsing-remitting and progressive multiple sclerosis
2009
Cerebrospinal fluid chitinase 3-like 1 levels are associated with conversion to multiple sclerosis
2010
Antibodies against endothelial cells in patients with multiple sclerosis
2009
MRI criteria for multiple sclerosis in patients presenting with clinically isolated syndromes: a multicentre retrospective study
2007
Elevated Epstein–Barr virus‐encoded nuclear antigen‐1 immune responses predict conversion to multiple sclerosis
2009
MRI characteristics of atypical idiopathic inflammatory demyelinating lesions of the brain
2007
MRI criteria for dissemination in space in patients with clinically isolated syndromes: a multicentre follow-up study
2006
Neuromyelitis optica diagnosis in clinically isolated syndromes suggestive of multiple sclerosis
2006
Utilidad clínica de las bandas oligoclonales
2001
Isolated demyelinating syndromes: comparison of different MR imaging criteria to predict conversion to clinically definite multiple sclerosis.
2000
Therapeutic Decisions in Multiple Sclerosis
2013
Baseline MRI predicts future attacks and disability in clinically isolated syndromes
2006
Clinical impact of intravenous methylprednisolone in attacks of multiple sclerosis
2004
Should we systematically test patients with clinically isolated syndrome for auto-antibodies?
2015
Spinal cord MRI should always be performed in clinically isolated syndrome patients: No
2014
Measures in the first year of therapy predict the response to interferon β in MS
2009
Expression of chemokine receptors in the different clinical forms of multiple sclerosis
2002
Early brain pseudoatrophy while on natalizumab therapy is due to white matter volume changes
2013
Emotional state of patients with relapsing-remitting MS treated with interferon beta-1b
1999
Primary Progressive Multiple Sclerosis Evolving From Radiologically Isolated Syndrome
2015
Isolated demyelinating syndromes: comparison of CSF oligoclonal bands and different MR imaging criteria to predict conversion to CDMS
2001
Value of NMO-IgG determination at the time of presentation as CIS
2012
Very early scans for demonstrating dissemination in time in multiple sclerosis
2008
New diagnostic criteria for multiple sclerosis
2003
Long-term emotional state of multiple sclerosis patients treated with interferon beta
2006
Evolution of multiple sclerosis lesions on serial contrast-enhanced T1-weighted and magnetization-transfer MR images.
2000
C onversion to multiple sclerosis after a clinically isolated syndrome of the brainstem: cranial magnetic resonance imaging, cerebrospinal fl uid and neurophysiological findings
2003
Low‐dose steroids reduce flu‐like symptoms at the initiation of IFNP‐1b in relapsing‐remitting MS
1998
Can the Expanded Disability Status Scale be assessed by telephone?
2003
Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis?
2007
A single-center, randomized, double-blind, placebo-controlled study of interferon beta-1b on primary progressive and transitional multiple sclerosis
2009
Factors related with treatment adherence to interferon b and glatiramer acetate therapy in multiple sclerosis
2005
Rankless by CCL
2026